TRUMF

PINK Terumo Corporation
Sep 30, 2026 · 9:46 AM ET EOD Market Open

$14.52 ↑ +0.69 (+4.98%) Trading Up from the previous close of $13.83, and at the day’s high of $14.52

YTD change
-4.03%
vs 20-day SMA
-2.13%
vs 200-day SMA
N/A

Price ranges

Previous day
$14.52 $14.52
open $14.52 close $14.52
+$0.00 (+0.00%)
Today
$14.52 $14.52
open $14.52 now $14.52
+$0.00 (+0.00%)
Past week
$13.83 $15.48
from $14.38 now $14.52
+$0.14 (+0.94%)
Past month
$12.76 $17.01
from $12.89 now $14.52
+$1.62 (+12.57%)
This year
$11.49 $17.01
from $15.12 now $14.52
-$0.61 (-4.03%)

Price & Performance

+1.42 (+10.86%) / 6M

$11.05$13.18$15.32$17.46Apr 6Jul 16Sep 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A
  • The stock is 22.0% away from all-time highs of $18.60
  • TRUMF is down 4% since the beginning of the year
  • TRUMF is down 4% over the past 12 months
  • TRUMF is up 13% over the past 1 month
  • 0% of all TRUMF investors are betting against TRUMF

TRUMF reads n/a: the 12-month move is -3.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes
EPS $0.2996
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Beta 1.10

Balance sheet & scale

Income$1.1M
Revenue$7.7B
Cash$1.9B
Debt$2.4M
Income / Debt 0.44×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK
Sector Manufacturing
Sub Sector Miscellaneous Manufacturing
Market cap $21.4B

Terumo Corp. engages in the manufacture and sale of medical products and equipment. It operates through the following segments: Cardiac and Vascular Company, General Hospital Company, and Blood Management Company. The Cardiac and Vascular Company segment offers services and treatments including cardiac and vascular surgery and interventional therapies performed inside blood vessels. The General Hospital Company segment provides infusion and closed anticancer drug infusion systems, measuring devices system with communication functions, diabetes management, adhesion barrier, and peritoneal dialysis. The Blood Management Company segment offers a combination of apheresis collections, manual and automated whole blood processing, and pathogen reduction. The company was founded by Shibasaburo Kitasato on September 17, 1921 and is headquartered in Tokyo, Japan.

Competitor comparison

TickerCompany PriceChange
JNJ.CAT JOHNSON & JOHNSON CDR CAD HEDGED $34.12 -1.73%
BDX Becton, Dickinson and Company $181.97 -1.01%
DXCM DexCom, Inc. $86.64 -0.05%
MDLN Medline, Inc. Class A $34.98 -0.26%
WST West Pharmaceutical Services, Inc. $376.63 +0.26%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.